Member Info for Dibs61

A placing @ 30%+ discount to market price?! And this was nearer to 190p recently. If you're a shareholder here you've gotta be spitting mad. Disastrous.

Oryx have taken a position here. Yet another respected institution climbs on board. The guy who runs the fund has won numerous investment awards - Christopher Mills. Yet another endorsement of ODX. Just a matter of time imo.

Going on here. Two 'sell' trades go through together - same price - but made to look different I couldn't get a dummy quote near 22.5 so games being played here. Suspect they're fishing for shares. They ain't getting mine!

Hi Falling, good call ere ;) But hey a hurricane would be good for reconstruction eh? :D

It could be that the distributors are required for the CE marked Malaria test or also the CD4 test? Whichever or both it's very positive and I imagine they will now wait for the trading update to advise. Think it's more likely next week.

Biggest clue yet that POC tests are about to take off in Africa? This has just been posted by ODX on Facebook: DISTRIBUTOR OPPORTUNITIES Interested in Distribution opportunities? Committed to global health issues? Have experience in Rapid Diagnostic Tests (RDTs) and Point of Care Technology (POCT)? An established footprint in the country where you currently work? We may have an opportunity just for YOU! Looking for Distributors across Africa. If interested, please send an email to odl@omegadiagnostics.co.uk and request a Global Health Distributor Form.

Placing has temporarily put the brakes on here. But plenty of sticky holders I reckon. So this looks like consolidating at this new level, perhaps for a while but good news flow here so who knows. Bullish.

Hughie Green moment is approaching here.

Algae has a piffling 4% stake here. Hmmm nice little earner for the old boy. Plenty of time for the golf course etc etc lol

Nearing a 6 month high. Is this yet another case of a SP telling us the underlying story? Yep I think so.

http://www.who.int/hiv/pub/journal_articles/JIAS_2013_PoC_CD4.pdf "Early results show that PoC CD4 can reduce time to eligibility assessment and losses to care prior to ART initiation, and the approach is promoted by the World Health Organization (WHO) as a way to improve access at peripheral sites [6]." This is Written evidence that CD4 POC testing is supported by World Health Organisation treatment strategy for HIV Omegas CD4 POC test is the only one in the market - currently zero competition BUY on CD4 final trial results due before end this year - likely in the trading update later this month.

Good to see a bit of posting and debate here today. I don't think there's a placing coming. The co have already advised me they've got €1.4m in cash dropping at end Oct

Quote: "The largest increase in CD4 test volumes will be driven by the adoption of POC devices, including device-free technologies, in either scenario." Hmmm now what have ODX been testing in final trials? Oh yes a CD4 (device free technology) POC test. You can lead a horse to water.....

Doubt it unv....:) But the market is not recognising the potential yet and that always provides opportunity

In 2015 the WHO produced the following report which forecast CD4 test sales of $141m in 2018 - that's £106m http://www.who.int/hiv/amds/110_Diagnostics-Manufacturer-Stakeholder-Meeting_CHAI.pdf ODX would only need to take a fraction of those sales next year for it to be transformative to their revenues. Be sure Omegas product is very much on WHO's radar and once Visitect CD4 is CE marked (forecast before end 2017) the final step will be to receive a 'prequisite' from WHO to trigger large volume orders which I strongly believe will be fast tracked due to the urgency of the situation) STRONG BUY. Can't say it any clearer than that. DYOR

Banging on about this but the market is asleep to the rerate potential based on the upcoming CD4 POC test - unique - that NO other company has in development. First sales should comfortably start in H1 2018. This product is DESPERATELY needed. Check out the following report. It may be 3 years old but no less relevant. Indeed it's MORE rekevant now. Omega are already recognised by WHO/UNITAIDS. This product will be sold in volume. http://www.who.int/hiv/events/UNITAID_Financing_for_POC.pdf POC CD4 tests are the future!

Bear necessities the simple bear necessities forget about your worry and your strife

@ 21.78p Trading update within two weeks - lots to report on. Confirmation of commercialisation of CD4 test by calendar year end = 🚀

For the patient BUY and tuck away. In a year you will likely have a bagger DYOR

But good support pops up @ 6p